Accredited Education

CME: Current Trends in Multiple Myeloma: Customizing Treatment Strategies and Optimizing Outcomes

TOPICS INCLUDE:

  • Advances in diagnosis and prognosis
  • Management of the newly diagnosed patient
  • Treatment advances and current management strategies for relapsed/refractory patients
  • Future treatment directions

AUTHOR
Thomas R. Chauncey, MD, PhD


Managing Administration and Toxicities of Therapies for Multiple Myeloma Patients

Presented by: Mary Theresa James, BSN
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Time to complete: 33 minutes
Activity start date: July 18, 2018
End date: July 17, 2019


The Impact on Patient Care

Presented by: Carol Ann Huff, MD
Medical Director Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Time to complete: 39 minutes
Activity start date: July 18, 2018
End date: July 17, 2019


Update on Smoldering Myeloma

At the completion of this module, participants should be able to:

Formulate criteria for identifying and managing smoldering multiple myeloma, including when to initiate treatments
Describe the clinical course and prognosis of smoldering asymptomatic multiple myeloma
Identify promising biomarkers in multiple myeloma


Update on Relapsed Myeloma

At the completion of this module, participants should be able to:

  • Choose among treatment options available for patients with early relapsed multiple myeloma
  • Identify which patients could benefit from salvage transplant in relapsed multiple myeloma
  • Optimize treatment plan for patient with relapsed refractory multiple myeloma
  • Manage disease and treatment complications in patients with relapsed multiple myeloma

Focus on Amyloidosis

At the completion of this module, participants should be able to:

  • Apply current diagnostic approaches to accurately identify the type of amyloidosis, measure the extent of organ involvement, and determine the patient’s prognosis
  • Prescribe the optimal treatment plan for patients with amyloidosis
  • Identify patients with amyloidosis who would benefit from autologous stem cell transplant

Updates in Preventing Skeletal-Related Events in Multiple Myeloma

CME / ABIM MOC / CE

Join Drs Raje and Roodman as they discuss how to optimally prevent and manage bone disease for patients with multiple myeloma.


Optimizing Frontline Care for Older Patients With Multiple Myeloma

CME / ABIM MOC
Medscape Education Oncology, June 2018
How do you assess your older patients with myeloma? Join Dr Rosko and Dr Wolf for critical points in treating older patients with MM.


Advances in Multiple Myeloma: Highlights and Data Analysis From Chicago and Stockholm

CME / ABIM MOC
Medscape Education Oncology, June 2018
Have you heard the latest news in myeloma? Hear key data from the 2018 summer congresses.


Assessing Newer Treatment Approaches for Multiply Relapsed Multiple Myeloma

CME / ABIM MOC / CE
April 2018
Hear 3 experts discuss how they incorporate newer therapies into the management of patients with multiply relapsed multiple myeloma.


Risk-Adapted Maintenance Strategies for Patients With Multiple Myeloma

Source: Expert Insights and Strategies to Improve Multiple Myeloma Care in an Environment of Continually Expanding Treatment Options and Clinical Complexity

Watch this video to see how Sagar Lonial, MD, uses genetic and disease risk factors to personalize maintenance strategies after autologous SCT for his patients with multiple myeloma.

Sagar Lonial, MD
Physicians: maximum of 0.25 AMA PRA Category 1 Credits™
Released: August 16, 2018 Expiration: August 15, 2019


Current Role of Transplantation for Patients With Newly Diagnosed Myeloma

Source: Expert Insights and Strategies to Improve Multiple Myeloma Care in an Environment of Continually Expanding Treatment Options and Clinical Complexity

Watch this video to hear when Sagar Lonial, MD, recommends transplantation for his patients with newly diagnosed myeloma.

Sagar Lonial, MD
Program Director
Physicians: maximum of 0.25 AMA PRA Category 1 Credits™
Released: July 24, 2018 Expiration: July 23, 2019


Advances in Multiple Myeloma

Release Date: August 21, 2015 | Expiration Date: August 21, 2016
Media: Print with online post-test, evaluation, and request for credit

Learning Objectives

After participating in this CME activity, learners should be better prepared to:

  • List recently approved treatments for multiple myeloma by class of agent
  • Summarize findings of elotuzumab from ELOQUENT-2
  • Describe outcomes data of carfilzomib from ENDEAVOR and ASPIRE
  • Identify the rationale for combining HDAC and proteasome inhibitors for the treatment of multiple myeloma

Medical Crossfire®: Personalizing Care for Multiple Myeloma Patients: Current and Future Sequencing Strategies

Release Date: August 21, 2015 | Expiration Date: August 21, 2016
Media: Print with online post-test, evaluation, and request for credit

Learning Objectives

By participating in this exciting program, you will learn about:

  • Factors that influence treatment decisions for newly diagnosed and relapsed/refractory MM
  • Adjunctive measures to decrease the likelihood of adverse events associated with treatments
  • Emerging data on novel MM therapies in late-stage development
  • Considerations when referring a patient for a clinical triala

Clinical Debates in Multiple Myeloma: Putting Evidence Into Context

Presenter: Sagar Lonial, MD, FACP
This activity reviews current treatments and therapies for the management of multiple myeloma.
Available credits: 1.00
Released: 05/23/2018
Valid until: 05/22/2019


Join Our Community

By joining the Myeloma360 community, you will receive regular updates with news, information, insights and expert opinions. 
Of course, you can opt out at any time.

Education CME Videos & Webcasts